Managed Account Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
$168M Sell
1,092,872
-450,173
-29% -$72.1M 0.14% 175
2015
Q1
$247M Sell
1,543,045
-153,890
-9% -$24.2M 0.22% 126
2014
Q4
$270M Buy
1,696,935
+75,528
+5% +$11.8M 0.27% 98
2014
Q3
$228M Sell
1,621,407
-14,336
-0.9% -$1.87M 0.25% 95
2014
Q2
$194M Buy
1,635,743
+5,884
+0.4% +$681K 0.23% 102
2014
Q1
$201M Sell
1,629,859
-122,387
-7% -$14.8M 0.26% 92
2013
Q4
$200M Buy
1,752,246
+116,488
+7% +$13.3M 0.27% 86
2013
Q3
$183M Sell
1,635,758
-25,508
-2% -$2.77M 0.27% 84
2013
Q2
$164M Buy
+1,661,266
New +$172M 0.25% 91

Other funds holding AMGN

Managed Account Advisors's AMGN Position: Q2 2015 in Review

Managed Account Advisors reduced its Amgen (AMGN) stake by 29% in Q2 2015, selling an estimated $72.1M and leaving 1,092,872 shares worth $168M. The position accounts for 0.14% of the portfolio, ranked #175.

Managed Account Advisors first reported a position in AMGN in Q2 2013 and has held it in 9 quarters since. The position peaked at $270M in Q4 2014. 1,367 funds tracked by Wall St. Rank hold AMGN as of Q2 2015.

  • Managed Account Advisors held 1,092,872 shares of Amgen worth $168M as of Q2 2015.
  • Managed Account Advisors sold 450,173 Amgen shares in Q2 2015, an estimated $72.1M.
  • Amgen made up 0.14% of Managed Account Advisors's portfolio in Q2 2015, its #175 holding.
  • Managed Account Advisors first reported a position in Amgen in Q2 2013 and has held it in 9 quarters since.
  • Managed Account Advisors's Amgen position peaked at $270M in Q4 2014.
  • 1,367 funds tracked by Wall St. Rank held Amgen as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.